论文部分内容阅读
目的探讨肝硬化合并难治性肝腹水患者的临床治疗。方法 80例肝硬化合并难治性肝腹水患者随机分为观察组与对照组,每组40例,观察组的患者采取常规治疗,对照组的患者在采取常规治疗的基础上再对其采用腹水超滤浓缩回输治疗,观察两组的治疗效果。结果观察组的患者总有效率为62.5%,对照组的患者总有效率为95.0%,两组总有效率差异有统计学意义(P<0.05)。结论对肝硬化合并难治性肝腹水患者采用腹水超滤浓缩回输治疗的效果显著,可以在临床上大力推广使用。
Objective To investigate the clinical treatment of patients with cirrhosis complicated with refractory liver ascites. Methods Eighty patients with cirrhosis complicated with refractory ascites were randomly divided into observation group and control group, 40 cases in each group. The patients in observation group were treated routinely. Patients in control group were treated with ascites Ultrafiltration concentrated infusion therapy, the two groups observed the therapeutic effect. Results The total effective rate was 62.5% in the observation group and 95.0% in the control group. The total effective rate was significantly different between the two groups (P <0.05). Conclusions The treatment of cirrhosis complicated with refractory ascites by ascites ultrafiltration concentrating transfusion therapy has a significant effect and can be widely used clinically.